INDUSTRY WORKSHOPS & SATELLITE SYMPOSIA
Sunday Morning, June 5
Breakfast: 0700-0800
Monday Morning, June 6
Breakfast: 0700-0800
Breakfast: 0730-0900
Tuesday Morning, June 7
Breakfast: 0700-0800
Tuesday Afternoon, June 7
Afternoon: 1600-1730
| SUNDAY JUNE 5 BREAKFAST |
|
| 0700-0800 |
|
 T501: Reporting of Colorectal Polyps – A pan-Canadian Consensus Approach
Speaker: Dr. David Driman, Chair: Colorectal Polyp Working Group, Canadian Partnership Against Cancer, Pathologist: Department of Pathology, London Health Sciences Centre, Professor: Department of Pathology, University of Western Ontario
In this session, the outcome of a recent pan-Canadian consensus meeting on reporting colorectal polyps will be presented. The session will focus on practical issues with diagnosing and reporting conventional adenomas as well as serrated polyps.
|
|
Go to top |
|
|
| MONDAY JUNE 6 BREAKFAST |
|
| 0700-0800 |
|
T601: GE Healthcare: Digital Pathology: A Clinician’s Perspective
Speaker: Jonhan Ho, M.D., M.S., University of Pittsburgh Medical Center, Director of Dermatopathology, Assistant Professor, Department of Dermatology
New digital innovations have the potential to change how pathology is practiced across Canada. Many pathologists, however, remain sceptical that they could use digital pathology for case review.
During this breakfast session, join GE Healthcare and dermatopathogist Dr. Jon Ho of UPMC to:
- Navigate a sample pathology workflow using GE Healthcare’s Omnyx Integrated Digital Pathology system;
- Understand the potential benefits and challenges of digital pathology versus current practice;
- Explore the implications of digital pathology for your practice and for the Canadian Healthcare system;
- Hear what pathologists demanded while designing GE Healthcare’s Omnyx Integrated Digital Pathology Solution.
Omnyx products are for research use only. Not for use in diagnostic procedures. Not licensed in accordance with Canadian law.
Dr. Jonhan Ho is a board certified dermatopathologist with board certifications in anatomic pathology, clinical pathology, and dermatopathology. He is a faculty member of the University of Pittsburgh, School of Medicine, in the Department of Dermatology, where he is the Director of Dermatopathology Resident Education. Dr. Ho also has a secondary appointment in the Department of Pathology.
Prior to his dermatopathology fellowship training, Dr. Ho completed a pathology informatics fellowship at the University of Pittsburgh, where he is also currently pursuing a Masters degree in the Department of Biomedical Informatics. Dr. Ho has several publications in the field of digital pathology and has been invited to speak on implementation of digital pathology at multiple national meetings. His research focuses on human computer interaction and translating digital slide technology into practice.
|
|
Go to top |
|
|
| 0730-0900 |
|
T602: Beckman Coulter Canada: The DxLab Workflow Manager - Not Just Another Middleware Product!
Speaker:Jeffrey Raponi, Market Development Manager, Clinical Information, Systems,Beckman Coulter Inc.
Introduction of the new DxLab Workflow Manager. It streamlines your workflow and improve quality management with an innovative graphical user interface and customized decision rules.
|
|
Go to top |
|
|
|
T603: Pre-analytical Variablility and Error Reduction in Anatomical Pathology
Speaker:Stephen S. Raab, MD, Professor, Vice-Chair of Surgical Pathology, Department of Pathology, University of Colorado
Errors and inefficiencies in diagnostic testing may occur in all steps of the testing process and some investigators hypothesize that problems in diagnostic testing occur most frequently in the pre- and post-analytic phases. For anatomic pathology testing, we reviewed the literature and performed observational studies evaluating the pre-analytic testing process steps. The data indicate that non-standard pre-analytic work practices result in less than optimal quality affecting the domains of safety, efficiency, timeliness, effectiveness, and patient centeredness. Problems in pre-analytic steps may result in errors that are compounded in analytic testing phase, such as errors in specimen integrity. Solutions to these problems involve the implementation of technologies and workflow change, such as the use of checklists and redundant practices.
|
|
Go to top |
|
|
|
T604: Quality Specifications, Sigma Metrics, and Quality Control: Managing Patient Risk by Aligning Process Capability and QC Design
Speaker:Dr. Curtis Parvin, Manager, Advanced Statistical Research, Bio-Rad Laboratories
Quality specifications dictate the performance characteristics that a test system must achieve in order for it to satisfy its intended purpose. Sigma metrics are a convenient mechanism for expressing the process capability of a test system by relating the amount of deviation a process can tolerate and remain within its quality specification. Quality control procedures aim to detect degradation in test system performance that would place patient results at risk of failing to meet their quality specifications. Thus, quality specifications, sigma metrics, and QC procedures are interrelated concepts that influence a laboratory’s ability to produce good patient results. This talk describes the relationships between quality specifications, sigma metrics, and quality control and discusses the implications for designing good quality control strategies.
|
|
Go to top |
|
|
|
T605: Vitamin D. Levels: Essentials, Assessment, Implications
Speaker:Dr. Nancy Haley, Siemens Healthcare Diagnostics
It has been long established that vitamin D plays an important role in good musculoskeletal health. There is also emerging evidence that inadequate vitamin D levels are associated with increased risk for certain cancers, autoimmune diseases, and cardiovascular disease. This presentation addresses essential background information (epidemiology, metabolism, and recommended range), key issues in assay management, and evidence that shows the association between inadequate vitamin D levels and the risk for certain diseases/conditions (musculoskeletal and non-musculoskeletal).
Objectives:
At the conclusion of this seminar, attendees should be able to:
- State the levels of vitamin D that are associated with deficiency, insufficiency, and sufficiency;
- State the importance of measuring a total vitamin D;
- Describe the association between vitamin D levels and disease risk.
|
|
Go to top |
|
|
|
| TUESDAY JUNE 7 BREAKFAST – 0700-0800 |
|
T701: Practical Clinical Use of Histology and Biomarkers in Non-small Cell Lung Carcinoma (NSCLC)
Speaker:Dr. Diana Ionescu, University of British Columbia
With the introduction of new diagnostic, predictive and prognostic tests, the world of oncologic pathology is constantly evolving. Keeping up to date with issues related to the clinical applications and practice of oncologic pathology has never been more challenging. You are invited to attend a Royal College MOC (Maintenance of Certification) Section 1 Credit Accredited Group Learning meeting, designed to meet the educational needs of Canadian healthcare providers involved in the diagnosis and management of patients with NSCLC.
|
|
Go to top |
|
|
|
| TUESDAY JUNE 7 AFTERNOON – 1600-1730 |
|
 T721: Alere: Use of Multiplex Methods for Diagnosis of Autoimmune Disease
Performance Evaluation of Test Systems for Autoantibodies to
Nuclear Antigens
Speaker: Dr. Michael Nimmo, Pathologist Vancouver Coastal Health Authority, Clinical Associate Professor, UBC, Director of Autoimmune Testing, Vancouver General Hospital
AtheNA Vasculitis Panel Evaluation – The Ottawa Experience
Speaker: Dr. Ronald Booth, Clinical Biochemist The Ottawa Hospital, Assistant Professor University of Ottawa
|
|
Go to top |
|
|
|
 T722: A Leading Canadian Hospital’s Experience with Lab Automation
Speaker: TBA
A presentation by a leading Canadian hospital’s clinical biochemist to share their lab’s story about moving to automation, implementation, results, key success factors, challenges, and tips.
|
|
Go to top |
|
|
|
 T723: Roche Diagnostics: Highly Sensitive Cardiac Troponin T, More Than You Want to Know
Speaker:Dr, Christopher deFilippi, MD, Associate Professor of Medecine, University of Maryland, Division of Cardiology
Talk objectives
- Determine the implications of migrating to a highly sensitive cTnT assay on the diagnosis and management of acute coronary syndromes;
- Evaluate the prognostic role of a highly sensitive cTnT assay in patients with coronary disease;
- Review the significance and cardiac findings associated with measurable levels of cTnT by the highly sensitive assay in patients without chest pain.
|
|
Go to top |
|
|
|
 T724: VF-1000 Using Fluorescent Flow Cytometry
Speaker: TBA
Introducing the VF-1000 and the technology used to enumerate WBC, RBC, bacteria and sedimentation.
|
|
Go to top |
|
|
|
 T725: Waters Corporation: Clinical MS Workshop
Tandem LCMS in the Clinical Laboratory: A Retrospective View
Speaker: Morris Pudek, Vancouver General Hospital, Vancouver, British Columbia
Implementation of LC-MS/MS Methodology for Analysis of Immunosuppressive Drugs
Speaker: Curtis Oleschuck, Diagnostic Services Of Manitoba, Winnipeg, Manitoba
Drug Screening and Analysis Using Tandem LCMS
Speaker: Denis Lehotay, Queen's University, Kingston, Ontario
|
|
Go to top |
|
|
|
CLMC Congress Secretariat
Tel: 613.531.9210
Fax: 613.531.0626
4 Cataraqui Street, Suite 310
Kingston, ON K7K 1Z7 Canada
|
